AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-84731959/genmab-and-paradigm-therapeutics.html" title="Facts and information about Genmab and Paradigm Therapeutics form drug development partnership.(Brief Article)">Genmab and Paradigm Therapeutics form drug development partnership.(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from M2 Europharma are available.
Frequently asked questions about RSS feeds
Genmab and Paradigm Therapeutics form drug development partnership.(Brief Article)
M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD
The Danish biotechnology company Genmab A/S and the British drug discovery firm Paradigm Therapeutics Ltd have joined forces to develop new antibody therapeutic products.
The partnership will utilise promising disease targets discovered by Paradigm and Genmab's fully human antibody technology to create and develop new drugs for a range of diseases, including cancer and inflammatory diseases.
The …
Related articles from newspapers, magazines, journals, and more
-
- Paradigm Therapeutics Ltd raises #12 M in Second Round Funding.
-
News wire article from: Asia Africa Intelligence Wire
December 9, 2002
700+ words
-
- Paradigm.
-
Newspaper article from: The Daily Deal
December 9, 2002
700+ words
